instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'IDARUCIZUMAB'? | Idarucizumab for dabigatran reversal in cardiac tamponade complicating percutaneous intervention in ST elevation myocardial infarction.
An 83-year-old man with a history of permanent atrial fibrillation (AF) anticoagulated by dabigatran 150 b.i.d., type 2 diabetes mellitus, and hypertension was admitted to the hospital... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 33868433 | 19,209,253 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Breast cancer metastatic'. | Olaparib in hormone receptor-positive, HER2-negative metastatic breast cancer with a somatic BRCA2 mutation.
The oral poly(adenosine diphosphate-ribose) polymerase inhibitor olaparib is approved for the treatment of patients with human epidermal growth factor 2-negative (HER2-) metastatic breast cancer (mBC) and a germ... | CARBOPLATIN | DrugsGivenReaction | CC BY-NC | 33868464 | 19,272,470 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Olaparib in hormone receptor-positive, HER2-negative metastatic breast cancer with a somatic BRCA2 mutation.
The oral poly(adenosine diphosphate-ribose) polymerase inhibitor olaparib is approved for the treatment of patients with human epidermal growth factor 2-negative (HER2-) metastatic breast cancer (mBC) and a germ... | CARBOPLATIN | DrugsGivenReaction | CC BY-NC | 33868464 | 19,272,470 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Palmar-plantar erythrodysaesthesia syndrome'. | Olaparib in hormone receptor-positive, HER2-negative metastatic breast cancer with a somatic BRCA2 mutation.
The oral poly(adenosine diphosphate-ribose) polymerase inhibitor olaparib is approved for the treatment of patients with human epidermal growth factor 2-negative (HER2-) metastatic breast cancer (mBC) and a germ... | CAPECITABINE | DrugsGivenReaction | CC BY-NC | 33868464 | 20,984,681 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Olaparib in hormone receptor-positive, HER2-negative metastatic breast cancer with a somatic BRCA2 mutation.
The oral poly(adenosine diphosphate-ribose) polymerase inhibitor olaparib is approved for the treatment of patients with human epidermal growth factor 2-negative (HER2-) metastatic breast cancer (mBC) and a germ... | CARBOPLATIN | DrugsGivenReaction | CC BY-NC | 33868464 | 19,272,470 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Yttrium-90 radioembolization in desmoplastic small round cell tumor with recurrent hepatic metastasis following hyperthermic intraperitoneal chemotherapy.
We report a case of a 26-year-old male who was diagnosed with metastatic desmoplastic small round cell tumor initially treated with systemic chemotherapy followed by... | TEMOZOLOMIDE, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 33868532 | 19,175,731 | 2021-06 |
What was the dosage of drug 'TEMOZOLOMIDE'? | Yttrium-90 radioembolization in desmoplastic small round cell tumor with recurrent hepatic metastasis following hyperthermic intraperitoneal chemotherapy.
We report a case of a 26-year-old male who was diagnosed with metastatic desmoplastic small round cell tumor initially treated with systemic chemotherapy followed by... | 1 CYCLE | DrugDosageText | CC BY-NC-ND | 33868532 | 19,175,731 | 2021-06 |
What was the dosage of drug 'VINCRISTINE'? | Yttrium-90 radioembolization in desmoplastic small round cell tumor with recurrent hepatic metastasis following hyperthermic intraperitoneal chemotherapy.
We report a case of a 26-year-old male who was diagnosed with metastatic desmoplastic small round cell tumor initially treated with systemic chemotherapy followed by... | 1 CYCLE | DrugDosageText | CC BY-NC-ND | 33868532 | 19,175,731 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | A case of hyperprogressive disease following atezolizumab therapy for pulmonary pleomorphic carcinoma with epidermal growth factor receptor mutation.
A 66-year old man with non-smoking history was diagnosed with pulmonary pleomorphic carcinoma of the right lower lobe. The carcinoma metastasized to the brain, lungs, ple... | CARBOPLATIN, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 33868915 | 19,321,757 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | A case of hyperprogressive disease following atezolizumab therapy for pulmonary pleomorphic carcinoma with epidermal growth factor receptor mutation.
A 66-year old man with non-smoking history was diagnosed with pulmonary pleomorphic carcinoma of the right lower lobe. The carcinoma metastasized to the brain, lungs, ple... | CARBOPLATIN, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 33868915 | 19,321,757 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Adenocarcinoma of the urethra: A rare subtype of urethral cancer.
Urethral adenocarcinoma (UA) is a rare type of urethral cancer with a poor prognosis. We present a case of UA of intestinal subtype in a 57-year-old patient who initially had lower urinary tract symptoms and was subsequently found to have a urethral lesi... | CAPECITABINE, FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC-ND | 33868934 | 19,656,564 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Adenocarcinoma of the urethra: A rare subtype of urethral cancer.
Urethral adenocarcinoma (UA) is a rare type of urethral cancer with a poor prognosis. We present a case of UA of intestinal subtype in a 57-year-old patient who initially had lower urinary tract symptoms and was subsequently found to have a urethral lesi... | CAPECITABINE, FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC-ND | 33868934 | 19,656,564 | 2021-07 |
What was the outcome of reaction 'Malignant neoplasm progression'? | Adenocarcinoma of the urethra: A rare subtype of urethral cancer.
Urethral adenocarcinoma (UA) is a rare type of urethral cancer with a poor prognosis. We present a case of UA of intestinal subtype in a 57-year-old patient who initially had lower urinary tract symptoms and was subsequently found to have a urethral lesi... | Fatal | ReactionOutcome | CC BY-NC-ND | 33868934 | 19,656,564 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acidosis'. | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | ACETAMINOPHEN, GABAPENTIN, MORPHINE | DrugsGivenReaction | CC BY | 33868959 | 19,214,506 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | ACETAMINOPHEN, GABAPENTIN, MORPHINE | DrugsGivenReaction | CC BY | 33868959 | 19,214,506 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Analgesic drug level increased'. | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | ACETAMINOPHEN, GABAPENTIN, MORPHINE | DrugsGivenReaction | CC BY | 33868959 | 19,214,506 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Continuous haemodiafiltration'. | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | ACETAMINOPHEN, GABAPENTIN, MORPHINE | DrugsGivenReaction | CC BY | 33868959 | 19,254,919 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | ACETAMINOPHEN, GABAPENTIN, MORPHINE | DrugsGivenReaction | CC BY | 33868959 | 19,254,919 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depressed level of consciousness'. | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | ACETAMINOPHEN, GABAPENTIN, MORPHINE | DrugsGivenReaction | CC BY | 33868959 | 19,262,187 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diffuse axonal injury'. | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | ACETAMINOPHEN, GABAPENTIN, MORPHINE | DrugsGivenReaction | CC BY | 33868959 | 19,262,187 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Endotracheal intubation'. | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | ACETAMINOPHEN, GABAPENTIN, MORPHINE | DrugsGivenReaction | CC BY | 33868959 | 19,254,919 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemodialysis'. | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | ACETAMINOPHEN, GABAPENTIN, MORPHINE | DrugsGivenReaction | CC BY | 33868959 | 19,254,919 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic failure'. | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | ACETAMINOPHEN, GABAPENTIN, MORPHINE | DrugsGivenReaction | CC BY | 33868959 | 19,254,919 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ileus'. | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | ACETAMINOPHEN, GABAPENTIN, MORPHINE | DrugsGivenReaction | CC BY | 33868959 | 19,262,187 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional overdose'. | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | ACETAMINOPHEN, GABAPENTIN, MORPHINE | DrugsGivenReaction | CC BY | 33868959 | 19,214,506 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal replacement therapy'. | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | ACETAMINOPHEN, GABAPENTIN, MORPHINE | DrugsGivenReaction | CC BY | 33868959 | 19,254,919 | 2021 |
What was the administration route of drug 'ACETAMINOPHEN'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Oral | DrugAdministrationRoute | CC BY | 33868959 | 19,262,187 | 2021 |
What was the administration route of drug 'ACETAMINOPHEN\HYDROCODONE'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Oral | DrugAdministrationRoute | CC BY | 33868959 | 19,183,261 | 2021 |
What was the administration route of drug 'GABAPENTIN'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Oral | DrugAdministrationRoute | CC BY | 33868959 | 19,262,187 | 2021 |
What was the administration route of drug 'MORPHINE'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Oral | DrugAdministrationRoute | CC BY | 33868959 | 19,262,187 | 2021 |
What was the dosage of drug 'ACETAMINOPHEN\HYDROCODONE'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | 50 G | DrugDosageText | CC BY | 33868959 | 19,183,261 | 2021 |
What was the outcome of reaction 'Acidosis'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,214,506 | 2021 |
What was the outcome of reaction 'Acute hepatic failure'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,262,187 | 2021 |
What was the outcome of reaction 'Brain oedema'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,262,187 | 2021 |
What was the outcome of reaction 'Cerebral haemorrhage'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,262,187 | 2021 |
What was the outcome of reaction 'Coagulopathy'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,262,187 | 2021 |
What was the outcome of reaction 'Continuous haemodiafiltration'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,254,919 | 2021 |
What was the outcome of reaction 'Death'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,254,919 | 2021 |
What was the outcome of reaction 'Depressed level of consciousness'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,262,187 | 2021 |
What was the outcome of reaction 'Diffuse axonal injury'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,262,187 | 2021 |
What was the outcome of reaction 'Endotracheal intubation'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,254,919 | 2021 |
What was the outcome of reaction 'Haemodialysis'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,254,919 | 2021 |
What was the outcome of reaction 'Hepatic failure'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,254,919 | 2021 |
What was the outcome of reaction 'Ileus'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,262,187 | 2021 |
What was the outcome of reaction 'Intentional overdose'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,214,506 | 2021 |
What was the outcome of reaction 'Mental status changes'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,262,187 | 2021 |
What was the outcome of reaction 'Metabolic acidosis'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,214,506 | 2021 |
What was the outcome of reaction 'Overdose'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,262,187 | 2021 |
What was the outcome of reaction 'Renal replacement therapy'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,254,919 | 2021 |
What was the outcome of reaction 'Toxicity to various agents'? | Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy.
Massive Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common presentation to emergency departments around the world. While N-acetylcysteine (NAC) remains the cornerstone of trea... | Fatal | ReactionOutcome | CC BY | 33868959 | 19,262,187 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases.
Pemetrexed and gemcitabine are both antimetabolites drugs approved in advanced non-small cell lung cancer (NSCLC). Their toxicity profile is well known. However,... | GEMCITABINE | DrugsGivenReaction | CC BY | 33869037 | 19,264,165 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin ulcer'. | Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases.
Pemetrexed and gemcitabine are both antimetabolites drugs approved in advanced non-small cell lung cancer (NSCLC). Their toxicity profile is well known. However,... | GEMCITABINE\GEMCITABINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33869037 | 19,222,662 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases.
Pemetrexed and gemcitabine are both antimetabolites drugs approved in advanced non-small cell lung cancer (NSCLC). Their toxicity profile is well known. However,... | GEMCITABINE | DrugsGivenReaction | CC BY | 33869037 | 19,264,165 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vasculitis'. | Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases.
Pemetrexed and gemcitabine are both antimetabolites drugs approved in advanced non-small cell lung cancer (NSCLC). Their toxicity profile is well known. However,... | GEMCITABINE\GEMCITABINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33869037 | 19,222,662 | 2021 |
What was the administration route of drug 'GEMCITABINE'? | Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases.
Pemetrexed and gemcitabine are both antimetabolites drugs approved in advanced non-small cell lung cancer (NSCLC). Their toxicity profile is well known. However,... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33869037 | 19,264,165 | 2021 |
What was the administration route of drug 'PEMETREXED'? | Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases.
Pemetrexed and gemcitabine are both antimetabolites drugs approved in advanced non-small cell lung cancer (NSCLC). Their toxicity profile is well known. However,... | Other | DrugAdministrationRoute | CC BY | 33869037 | 19,351,405 | 2021 |
What was the dosage of drug 'CISPLATIN'? | Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases.
Pemetrexed and gemcitabine are both antimetabolites drugs approved in advanced non-small cell lung cancer (NSCLC). Their toxicity profile is well known. However,... | 6 CYCLES | DrugDosageText | CC BY | 33869037 | 19,351,405 | 2021 |
What was the dosage of drug 'GEMCITABINE HYDROCHLORIDE'? | Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases.
Pemetrexed and gemcitabine are both antimetabolites drugs approved in advanced non-small cell lung cancer (NSCLC). Their toxicity profile is well known. However,... | UNK, CYCLIC | DrugDosageText | CC BY | 33869037 | 19,245,962 | 2021 |
What was the outcome of reaction 'Skin ulcer'? | Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases.
Pemetrexed and gemcitabine are both antimetabolites drugs approved in advanced non-small cell lung cancer (NSCLC). Their toxicity profile is well known. However,... | Not recovered | ReactionOutcome | CC BY | 33869037 | 19,222,662 | 2021 |
What was the outcome of reaction 'Vasculitis'? | Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases.
Pemetrexed and gemcitabine are both antimetabolites drugs approved in advanced non-small cell lung cancer (NSCLC). Their toxicity profile is well known. However,... | Not recovered | ReactionOutcome | CC BY | 33869037 | 19,222,662 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bronchial hyperreactivity'. | Case Report: Maintenance of Desensitization to Nebulized Colomycin Over 10 Years.
Drug desensitization can be achieved successfully by gradual drug dose increases in different protocols. Most protocols are designed to obtain temporal tolerance. The data on long-term maintenance of drug tolerance is scarce. Based on an ... | CEFTAZIDIME, CIPROFLOXACIN, COLISTIN SULFATE, FLUCLOXACILLIN, TOBRAMYCIN | DrugsGivenReaction | CC BY | 33869120 | 19,648,646 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pathogen resistance'. | Case Report: Maintenance of Desensitization to Nebulized Colomycin Over 10 Years.
Drug desensitization can be achieved successfully by gradual drug dose increases in different protocols. Most protocols are designed to obtain temporal tolerance. The data on long-term maintenance of drug tolerance is scarce. Based on an ... | CEFTAZIDIME, CIPROFLOXACIN, COLISTIN SULFATE, FLUCLOXACILLIN, TOBRAMYCIN | DrugsGivenReaction | CC BY | 33869120 | 19,623,920 | 2021 |
What was the administration route of drug 'CEFTAZIDIME'? | Case Report: Maintenance of Desensitization to Nebulized Colomycin Over 10 Years.
Drug desensitization can be achieved successfully by gradual drug dose increases in different protocols. Most protocols are designed to obtain temporal tolerance. The data on long-term maintenance of drug tolerance is scarce. Based on an ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33869120 | 19,648,646 | 2021 |
What was the administration route of drug 'COLISTIN SULFATE'? | Case Report: Maintenance of Desensitization to Nebulized Colomycin Over 10 Years.
Drug desensitization can be achieved successfully by gradual drug dose increases in different protocols. Most protocols are designed to obtain temporal tolerance. The data on long-term maintenance of drug tolerance is scarce. Based on an ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33869120 | 19,648,646 | 2021 |
What was the administration route of drug 'FLUCLOXACILLIN'? | Case Report: Maintenance of Desensitization to Nebulized Colomycin Over 10 Years.
Drug desensitization can be achieved successfully by gradual drug dose increases in different protocols. Most protocols are designed to obtain temporal tolerance. The data on long-term maintenance of drug tolerance is scarce. Based on an ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33869120 | 19,648,646 | 2021 |
What was the administration route of drug 'TOBRAMYCIN'? | Case Report: Maintenance of Desensitization to Nebulized Colomycin Over 10 Years.
Drug desensitization can be achieved successfully by gradual drug dose increases in different protocols. Most protocols are designed to obtain temporal tolerance. The data on long-term maintenance of drug tolerance is scarce. Based on an ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33869120 | 19,648,646 | 2021 |
What was the dosage of drug 'COLISTIN SULFATE'? | Case Report: Maintenance of Desensitization to Nebulized Colomycin Over 10 Years.
Drug desensitization can be achieved successfully by gradual drug dose increases in different protocols. Most protocols are designed to obtain temporal tolerance. The data on long-term maintenance of drug tolerance is scarce. Based on an ... | NEBULISED | DrugDosageText | CC BY | 33869120 | 19,623,920 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection.
Suppressive parenteral antibiotic therapy with beta-lactams may be necessary in patients with Gram-negative bone and joint infection (BJI). Subcutan... | ERTAPENEM | DrugsGivenReaction | CC BY | 33869238 | 20,990,378 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection.
Suppressive parenteral antibiotic therapy with beta-lactams may be necessary in patients with Gram-negative bone and joint infection (BJI). Subcutan... | CILASTATIN SODIUM\IMIPENEM, CIPROFLOXACIN, ERTAPENEM, FLUCONAZOLE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 33869238 | 19,459,985 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pathogen resistance'. | Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection.
Suppressive parenteral antibiotic therapy with beta-lactams may be necessary in patients with Gram-negative bone and joint infection (BJI). Subcutan... | CILASTATIN SODIUM\IMIPENEM, CIPROFLOXACIN, ERTAPENEM, FLUCONAZOLE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 33869238 | 19,459,985 | 2021 |
What is the weight of the patient? | Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection.
Suppressive parenteral antibiotic therapy with beta-lactams may be necessary in patients with Gram-negative bone and joint infection (BJI). Subcutan... | 74 kg. | Weight | CC BY | 33869238 | 20,990,378 | 2021 |
What was the administration route of drug 'CILASTATIN SODIUM\IMIPENEM'? | Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection.
Suppressive parenteral antibiotic therapy with beta-lactams may be necessary in patients with Gram-negative bone and joint infection (BJI). Subcutan... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33869238 | 19,459,985 | 2021 |
What was the administration route of drug 'CIPROFLOXACIN'? | Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection.
Suppressive parenteral antibiotic therapy with beta-lactams may be necessary in patients with Gram-negative bone and joint infection (BJI). Subcutan... | Oral | DrugAdministrationRoute | CC BY | 33869238 | 19,459,985 | 2021 |
What was the administration route of drug 'FLUCONAZOLE'? | Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection.
Suppressive parenteral antibiotic therapy with beta-lactams may be necessary in patients with Gram-negative bone and joint infection (BJI). Subcutan... | Oral | DrugAdministrationRoute | CC BY | 33869238 | 19,459,985 | 2021 |
What was the dosage of drug 'SODIUM CHLORIDE'? | Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection.
Suppressive parenteral antibiotic therapy with beta-lactams may be necessary in patients with Gram-negative bone and joint infection (BJI). Subcutan... | 50 MILLILITER | DrugDosageText | CC BY | 33869238 | 19,459,985 | 2021 |
What was the administration route of drug 'AMINOSALICYLIC ACID'? | Prolonged use of bedaquiline in two patients with pulmonary extensively drug-resistant tuberculosis: Two case reports.
BACKGROUND
Bedaquiline is among the prioritized drugs recommended by the World Health Organization for the treatment of extensively drug-resistant tuberculosis (XDR-TB). Many patients have not achieved... | Oral | DrugAdministrationRoute | CC BY-NC | 33869610 | 20,736,074 | 2021-04-06 |
What was the administration route of drug 'CAPREOMYCIN'? | Prolonged use of bedaquiline in two patients with pulmonary extensively drug-resistant tuberculosis: Two case reports.
BACKGROUND
Bedaquiline is among the prioritized drugs recommended by the World Health Organization for the treatment of extensively drug-resistant tuberculosis (XDR-TB). Many patients have not achieved... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33869610 | 20,736,074 | 2021-04-06 |
What was the administration route of drug 'ISONIAZID'? | Prolonged use of bedaquiline in two patients with pulmonary extensively drug-resistant tuberculosis: Two case reports.
BACKGROUND
Bedaquiline is among the prioritized drugs recommended by the World Health Organization for the treatment of extensively drug-resistant tuberculosis (XDR-TB). Many patients have not achieved... | Oral | DrugAdministrationRoute | CC BY-NC | 33869610 | 20,737,539 | 2021-04-06 |
What was the administration route of drug 'PROTIONAMIDE'? | Prolonged use of bedaquiline in two patients with pulmonary extensively drug-resistant tuberculosis: Two case reports.
BACKGROUND
Bedaquiline is among the prioritized drugs recommended by the World Health Organization for the treatment of extensively drug-resistant tuberculosis (XDR-TB). Many patients have not achieved... | Oral | DrugAdministrationRoute | CC BY-NC | 33869610 | 20,736,074 | 2021-04-06 |
What was the administration route of drug 'PYRAZINAMIDE'? | Prolonged use of bedaquiline in two patients with pulmonary extensively drug-resistant tuberculosis: Two case reports.
BACKGROUND
Bedaquiline is among the prioritized drugs recommended by the World Health Organization for the treatment of extensively drug-resistant tuberculosis (XDR-TB). Many patients have not achieved... | Oral | DrugAdministrationRoute | CC BY-NC | 33869610 | 20,736,074 | 2021-04-06 |
What was the administration route of drug 'RIFAMPIN'? | Prolonged use of bedaquiline in two patients with pulmonary extensively drug-resistant tuberculosis: Two case reports.
BACKGROUND
Bedaquiline is among the prioritized drugs recommended by the World Health Organization for the treatment of extensively drug-resistant tuberculosis (XDR-TB). Many patients have not achieved... | Oral | DrugAdministrationRoute | CC BY-NC | 33869610 | 20,961,425 | 2021-04-06 |
What was the dosage of drug 'ETHAMBUTOL HYDROCHLORIDE'? | Prolonged use of bedaquiline in two patients with pulmonary extensively drug-resistant tuberculosis: Two case reports.
BACKGROUND
Bedaquiline is among the prioritized drugs recommended by the World Health Organization for the treatment of extensively drug-resistant tuberculosis (XDR-TB). Many patients have not achieved... | 750 MG/D, Q.D., P.O. | DrugDosageText | CC BY-NC | 33869610 | 20,965,121 | 2021-04-06 |
What was the dosage of drug 'LEVOFLOXACIN'? | Prolonged use of bedaquiline in two patients with pulmonary extensively drug-resistant tuberculosis: Two case reports.
BACKGROUND
Bedaquiline is among the prioritized drugs recommended by the World Health Organization for the treatment of extensively drug-resistant tuberculosis (XDR-TB). Many patients have not achieved... | 500 MG, QD, PO | DrugDosageText | CC BY-NC | 33869610 | 20,965,121 | 2021-04-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute hepatic failure'. | Thyroid Disease-Induced Hepatic Dysfunction: A Clinical Puzzle.
The diagnostic evaluation of an individual with clinical and laboratory evidence of thyroid dysfunction in the setting of acute liver injury is crucial. There is a complex relationship between the thyroid and the liver, and so, it requires a careful elucid... | METHIMAZOLE, WARFARIN | DrugsGivenReaction | CC BY | 33869649 | 20,911,598 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebral atrophy'. | Thyroid Disease-Induced Hepatic Dysfunction: A Clinical Puzzle.
The diagnostic evaluation of an individual with clinical and laboratory evidence of thyroid dysfunction in the setting of acute liver injury is crucial. There is a complex relationship between the thyroid and the liver, and so, it requires a careful elucid... | METHIMAZOLE, WARFARIN | DrugsGivenReaction | CC BY | 33869649 | 20,911,598 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coagulopathy'. | Thyroid Disease-Induced Hepatic Dysfunction: A Clinical Puzzle.
The diagnostic evaluation of an individual with clinical and laboratory evidence of thyroid dysfunction in the setting of acute liver injury is crucial. There is a complex relationship between the thyroid and the liver, and so, it requires a careful elucid... | METHIMAZOLE, WARFARIN | DrugsGivenReaction | CC BY | 33869649 | 20,911,598 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Congestive hepatopathy'. | Thyroid Disease-Induced Hepatic Dysfunction: A Clinical Puzzle.
The diagnostic evaluation of an individual with clinical and laboratory evidence of thyroid dysfunction in the setting of acute liver injury is crucial. There is a complex relationship between the thyroid and the liver, and so, it requires a careful elucid... | METHIMAZOLE, WARFARIN | DrugsGivenReaction | CC BY | 33869649 | 20,911,598 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Thyroid Disease-Induced Hepatic Dysfunction: A Clinical Puzzle.
The diagnostic evaluation of an individual with clinical and laboratory evidence of thyroid dysfunction in the setting of acute liver injury is crucial. There is a complex relationship between the thyroid and the liver, and so, it requires a careful elucid... | METHIMAZOLE, WARFARIN | DrugsGivenReaction | CC BY | 33869649 | 20,911,598 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug-induced liver injury'. | Thyroid Disease-Induced Hepatic Dysfunction: A Clinical Puzzle.
The diagnostic evaluation of an individual with clinical and laboratory evidence of thyroid dysfunction in the setting of acute liver injury is crucial. There is a complex relationship between the thyroid and the liver, and so, it requires a careful elucid... | METHIMAZOLE, WARFARIN | DrugsGivenReaction | CC BY | 33869649 | 20,911,598 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Encephalopathy'. | Thyroid Disease-Induced Hepatic Dysfunction: A Clinical Puzzle.
The diagnostic evaluation of an individual with clinical and laboratory evidence of thyroid dysfunction in the setting of acute liver injury is crucial. There is a complex relationship between the thyroid and the liver, and so, it requires a careful elucid... | METHIMAZOLE, WARFARIN | DrugsGivenReaction | CC BY | 33869649 | 20,911,598 | 2021-04 |
What was the dosage of drug 'METHIMAZOLE'? | Thyroid Disease-Induced Hepatic Dysfunction: A Clinical Puzzle.
The diagnostic evaluation of an individual with clinical and laboratory evidence of thyroid dysfunction in the setting of acute liver injury is crucial. There is a complex relationship between the thyroid and the liver, and so, it requires a careful elucid... | UNK (RESTARTED) | DrugDosageText | CC BY | 33869649 | 20,911,598 | 2021-04 |
What was the outcome of reaction 'Acute hepatic failure'? | Thyroid Disease-Induced Hepatic Dysfunction: A Clinical Puzzle.
The diagnostic evaluation of an individual with clinical and laboratory evidence of thyroid dysfunction in the setting of acute liver injury is crucial. There is a complex relationship between the thyroid and the liver, and so, it requires a careful elucid... | Recovering | ReactionOutcome | CC BY | 33869649 | 20,911,598 | 2021-04 |
What was the outcome of reaction 'Cerebral atrophy'? | Thyroid Disease-Induced Hepatic Dysfunction: A Clinical Puzzle.
The diagnostic evaluation of an individual with clinical and laboratory evidence of thyroid dysfunction in the setting of acute liver injury is crucial. There is a complex relationship between the thyroid and the liver, and so, it requires a careful elucid... | Recovering | ReactionOutcome | CC BY | 33869649 | 20,911,598 | 2021-04 |
What was the outcome of reaction 'Coagulopathy'? | Thyroid Disease-Induced Hepatic Dysfunction: A Clinical Puzzle.
The diagnostic evaluation of an individual with clinical and laboratory evidence of thyroid dysfunction in the setting of acute liver injury is crucial. There is a complex relationship between the thyroid and the liver, and so, it requires a careful elucid... | Recovering | ReactionOutcome | CC BY | 33869649 | 20,911,598 | 2021-04 |
What was the outcome of reaction 'Congestive hepatopathy'? | Thyroid Disease-Induced Hepatic Dysfunction: A Clinical Puzzle.
The diagnostic evaluation of an individual with clinical and laboratory evidence of thyroid dysfunction in the setting of acute liver injury is crucial. There is a complex relationship between the thyroid and the liver, and so, it requires a careful elucid... | Recovering | ReactionOutcome | CC BY | 33869649 | 20,911,598 | 2021-04 |
What was the outcome of reaction 'Drug-induced liver injury'? | Thyroid Disease-Induced Hepatic Dysfunction: A Clinical Puzzle.
The diagnostic evaluation of an individual with clinical and laboratory evidence of thyroid dysfunction in the setting of acute liver injury is crucial. There is a complex relationship between the thyroid and the liver, and so, it requires a careful elucid... | Recovering | ReactionOutcome | CC BY | 33869649 | 20,911,598 | 2021-04 |
What was the outcome of reaction 'Encephalopathy'? | Thyroid Disease-Induced Hepatic Dysfunction: A Clinical Puzzle.
The diagnostic evaluation of an individual with clinical and laboratory evidence of thyroid dysfunction in the setting of acute liver injury is crucial. There is a complex relationship between the thyroid and the liver, and so, it requires a careful elucid... | Recovering | ReactionOutcome | CC BY | 33869649 | 20,911,598 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiopulmonary failure'. | Fatal immune-related hepatitis with intrahepatic cholestasis and pneumonia associated with camrelizumab: A case report and literature review.
Camrelizumab (SHR-1210), a human monoclonal antibody against programmed death receptor 1 (PD-1), blocks the binding of PD-1 to PD-L1, consequently inhibiting immune system evasio... | ALBUMIN HUMAN, CAMRELIZUMAB, CAPECITABINE, CASPOFUNGIN, CEFOPERAZONE\SULBACTAM, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, URSODIOL | DrugsGivenReaction | CC BY | 33869777 | 19,555,242 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Fatal immune-related hepatitis with intrahepatic cholestasis and pneumonia associated with camrelizumab: A case report and literature review.
Camrelizumab (SHR-1210), a human monoclonal antibody against programmed death receptor 1 (PD-1), blocks the binding of PD-1 to PD-L1, consequently inhibiting immune system evasio... | ALBUMIN HUMAN, CAMRELIZUMAB, CAPECITABINE, CASPOFUNGIN, CEFOPERAZONE\SULBACTAM, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, URSODIOL | DrugsGivenReaction | CC BY | 33869777 | 19,555,242 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic failure'. | Fatal immune-related hepatitis with intrahepatic cholestasis and pneumonia associated with camrelizumab: A case report and literature review.
Camrelizumab (SHR-1210), a human monoclonal antibody against programmed death receptor 1 (PD-1), blocks the binding of PD-1 to PD-L1, consequently inhibiting immune system evasio... | ALBUMIN HUMAN, CAMRELIZUMAB, CAPECITABINE, CASPOFUNGIN, CEFOPERAZONE\SULBACTAM, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, URSODIOL | DrugsGivenReaction | CC BY | 33869777 | 19,555,242 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.